Clinical research

Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial

EuroIntervention 2012;7:1021-1029. DOI: 10.4244/EIJV7I9A164

Helen Boden
Helèn Boden1, MD; Bas L. van der Hoeven1, MD, PhD; Su-San Liem1, MD, PhD; Jael Z. Atary1, MD, PhD; Suzanne C. Cannegieter², MD, PhD; Douwe E. Atsma1, MD, PhD; Marianne Bootsma1, MD, PhD; J. Wouter Jukema1, MD, PhD; Katja Zeppenfeld1, MD, PhD; Pranobe V. Oemrawsingh3, MD, PhD; Ernst E. van der Wall1, MD, PhD; Martin J. Schalij1*, MD, PhD.
1. Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; 2. Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; 3. Department of Cardiology, Medical Center Haagl

Aims: To evaluate the clinical outcomes of sirolimus-eluting stent (SES) versus bare metal stent (BMS) implantation in patients with ST-segment elevation myocardial infar

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

stemiprimary angioplastyclinical researchbare metal stentstent thrombosis
Read next article
Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents

Latest news